Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:

NCT ID: NCT03227679 Completed - Tobacco Use Clinical Trials

Metabolism-informed Care for Smoking Cessation

Start date: May 18, 2016
Phase: N/A
Study type: Interventional

Nicotine mediates smoking's addictive effects in the brain. The ratio of 3-hydroxycotinine to cotinine, known as the nicotine metabolite ratio, or NMR, is a genetically- informed biomarker reflecting hepatic CYP2A6 activity and the rate of nicotine metabolism. In light of a recent randomized controlled trial (RCT) in humans in Lancet Respiratory Medicine, which found that the NMR can be used to individualize treatment for smokers, our pilot study aims to determine the feasibility of using NMR to guide selection of pharmacotherapy in clinical populations of daily smokers.

NCT ID: NCT03209557 Completed - Pregnancy Related Clinical Trials

Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women

Start date: July 5, 2017
Phase: N/A
Study type: Interventional

Investigators will assess the feasibility of implementing a randomized control trial of a behavioral intervention that uses smartwatch technology to monitor smoking behavior with texts aimed at reducing smoking in pregnant women who smoke. Investigators will compare the cessation rate of pregnant women who receive usual care through programs aimed at reducing smoking with pregnant women who receive usual care and are using the SmokeBeat app with a smartwatch.

NCT ID: NCT03194958 Completed - Smoking Cessation Clinical Trials

Helping Poor Smokers Quit

Start date: June 5, 2017
Phase: N/A
Study type: Interventional

Using a 2x2 randomized factorial design, we will conduct a statewide field trial in Missouri to compare the relative and combined effects of these two strategies for augmenting an existing, evidence-based tobacco quitline program. Among 2000 low-income smokers, half will receive standard Missouri quitline services and half will receive new Specialized Quitline services targeted to this group. In each of these groups, half also will receive calls from a trained navigator to help them address unmet Basic Needs and the accompanying psychological distress that act as barriers to smoking cessation.

NCT ID: NCT03168451 Completed - Clinical trials for Tobacco Use Cessation

American Indians STOp Smoking by Mobile Phone

AI STOMP
Start date: November 30, 2015
Phase: N/A
Study type: Interventional

In an attempt to reduce smoking-related health disparities, investigators will implement a text messaging-based smoking cessation intervention in collaboration with state quit lines. The approach is based on the successful STOMP (STOp smoking by Mobile Phone) program, a text messaging-based smoking cessation intervention among young Maori adults in New Zealand. Investigators will adapt the STOMP intervention, which will result in a new intervention known as AI STOMP (American Indians STOp smoking by Mobile Phone).The primary aim of the study is to determine the effectiveness of the AI-STOMP intervention in smoking cessation among American Indians.

NCT ID: NCT03064971 Completed - Clinical trials for Tobacco Use Cessation

Enhancing Quitline Services for African American Smokers

Start date: May 22, 2017
Phase: N/A
Study type: Interventional

This study proposes to test the value of a culturally specific program for African American smokers to quit smoking.

NCT ID: NCT02735382 Completed - Clinical trials for Tobacco Use Cessation

EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study

Start date: September 2016
Phase: N/A
Study type: Interventional

This study is designed to assess whether completely electronic, HIPAA-compliant, EHR-based, closed-loop referrals for tobacco cessation from primary care clinics to a state telephone tobacco quitline service can increase the number/percentage of adult tobacco users receiving evidence-based tobacco dependence treatment when compared to paper-based fax referrals. This study also will survey clinic staff to evaluate satisfaction with the referral process.

NCT ID: NCT02721082 Completed - Clinical trials for Tobacco Use Cessation

Changing the Default for Tobacco Treatment

Start date: September 1, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the impact and efficacy of a new approach to smoking cessation treatment versus the traditional approach.

NCT ID: NCT02596711 Completed - Clinical trials for Tobacco Use Cessation

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

Start date: November 2, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this research study is to learn how 3 different kinds of counseling treatments may help individuals to quit smoking.

NCT ID: NCT02571244 Completed - Clinical trials for Tobacco Use Disorder

Text Messaging for Supporting Quit Attempts

Start date: June 2015
Phase: N/A
Study type: Interventional

This study is a preliminary research aimed to compare the feasibility and effectiveness of motivational interview (MI), Personalized text messages (TM) and usual care for outpatients, with focus on smoking cessation as the main outcome. Smokers patients have received brief interventions and nicotine replacement therapy during the hospitalization. After discharge smokers were allocated into a intervention or control arm. In the first and third months, after randomization, the patients were contact to smoke abstinence assessment.

NCT ID: NCT02564653 Completed - Clinical trials for Tobacco Use Cessation

Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam Public Health System

Start date: August 2015
Phase: N/A
Study type: Interventional

Vietnam has a smoking prevalence that is the second highest among South East Asian countries (SEACs). With a population of approximately 90 million, Vietnam also has the second largest total number of adult smokers (over 16 million) in SEA. According to the World Health Organization (WHO), most reductions in mortality from tobacco use in the near future will be achieved through helping current users quit. Tobacco use treatment, as defined by the U.S. Preventive Health Service Guideline (Guideline) on Treating Tobacco use and Dependence, is evidence-based and highly cost-effective. Yet, in the U.S. and globally, adoption of recommended care is suboptimal. The objective of this proposal is to fill the current research-to-practice gap by conducting a randomized controlled trial that compares the effectiveness and cost effectiveness of two practical and highly replicable strategies for implementing evidence-based guidelines for the treatment of tobacco use in public health clinics in Vietnam. The proposed implementation strategies draw on evidence-based approaches, and the WHO's recently released guidelines for implementing Article 14 of the Framework Convention on Tobacco Control (FCTC). The FCTC is an evidence-based treaty that was developed by the WHO in response to the globalization of the tobacco epidemic. Vietnam ratified the FCTC in 2004; however, they have not taken steps to implement Article 14 which specifies the need to integrate best practices for treating tobacco use and dependence into routine preventive care. The proposed implementation strategies also build on the growing literature that supports the effectiveness of integrating community health workers as members of the health care team to improve access to preventive services.